Commercial fusion energy has moved from a distant public-research goal to a well-funded private race, and its patent landscape is being staked out as companies compress decades of physics into engineering programs. Fusion fuses light nuclei to release energy, and its progress is measured by the fusion gain, or Q, and the triple product of density, temperature, and confinement time, the parameters that determine whether a device produces more energy than it consumes.³ It is pursued through several competing confinement approaches, each a distinct region of patenting: magnetic confinement, including tokamaks, spherical tokamaks such as Globus-M2, stellarators, mirrors, and field-reversed configurations; inertial confinement using lasers; and magneto-inertial hybrids, running on fuels such as deuterium-tritium, deuterium-deuterium, and proton-boron.⁵ The intellectual property divides across the enabling technologies these approaches share: the magnets that confine the plasma, especially high-temperature superconducting magnets; the systems that heat and control the plasma; the tritium breeding blankets that must produce fuel and capture energy; the first-wall and divertor materials that survive intense neutron flux; and, for inertial approaches, the targets and drivers, whose implosion physics is an active research area.¹,⁶ Because a viable plant depends on several of these layers, freedom-to-operate and white space analysis must span the confinement approaches and the enabling layers together.

The landscape is being reshaped by a technology shift and a funding boom. High-temperature superconducting magnets, which reach much stronger fields than conventional superconductors, allow far more compact and potentially cheaper machines: the SPARC device, for example, is designed around a high-field, compact tokamak concept, and the physics basis for such burning-plasma machines is now well documented.² The 2025 edition of the IAEA's World Fusion Outlook gave these magnets a special focus, reflecting their role across tokamaks, stellarators, and mirror concepts.⁹ Public milestones anchor the field: in December 2022 the US National Ignition Facility achieved fusion ignition, producing about 3.15 megajoules of fusion energy from about 2.05 megajoules of laser energy delivered to the target, a scientific, target-level energy gain rather than a net-grid gain, and later experiments repeated ignition.⁷ On the magnetic side, ITER's 2024 re-baseline set the start of research operations in 2034 and the start of deuterium-tritium operations in 2039, a four-year delay from the earlier reference, and changed the first-wall material from beryllium to tungsten.⁸ Public programs are also advancing the physics, as with China's HL-3 tokamak.⁴ The intellectual-property picture is therefore a mix, because much of the underlying plasma physics is in the public domain from decades of open research, while the proprietary value concentrates in the specific engineering that turns physics into a machine. That split is visible in the record: across the Cypris corpus of more than 500 million patents and scientific papers, the fusion set holds on the order of 11,694 families and grew from about 376 in 2020 to roughly 711 in 2024, with the most active assignees being public institutes and diversified industrials, led by the Hefei Institutes of Physical Science of the Chinese Academy of Sciences alongside Toshiba, Hitachi, and the Japan Atomic Energy Agency, and China ahead of the United States and the United Kingdom on geography; 2025 and 2026 counts are partial because of the publication lag.

The strategic question is which enabling layer to own, and the white space sits where engineering, not physics, is the barrier. High-temperature superconducting magnet design and the manufacturing of the superconducting tape and cable are a high-value layer where a compact-machine advantage is won.² Tritium breeding, producing more tritium than the plant consumes, has not been demonstrated at commercial scale and is a critical, comparatively open area, as are the first-wall and divertor materials that must withstand neutron damage over a plant's life. Plasma heating and control, increasingly aided by machine learning, and, for inertial approaches, target fabrication and drivers, are further contested layers.⁶ Private-venture pilot-plant dates and net-gain targets should be read as company projections rather than demonstrated results. Reading the landscape by approach, enabling layer, and owner, and tracking both the patents and the underlying fusion-science research, is what separates a crowded region from an open one.

Where the fusion white space is

High-temperature superconducting magnets. Magnet design and the manufacturing of superconducting tape and cable for compact, high-field machines are a high-value, capital-intensive layer.²

Tritium breeding blankets. Breeding more tritium than the plant consumes, and capturing the fusion energy, is unproven at commercial scale and a critical, comparatively open area.

First-wall and divertor materials. Materials such as tungsten that survive intense neutron flux over a plant's life, and the strategies to replace them, are a distinct, high-stakes engineering layer.⁸

Plasma heating and control. Systems that heat, shape, and stabilize the plasma, increasingly using machine learning, are an active and contested layer.

Inertial targets and drivers. For inertial-confinement approaches, target fabrication and driver technologies are a separate region of patenting.¹,⁶

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans several confinement approaches and enabling layers, built on public physics but proprietary engineering, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by approach and enabling layer across varied terminology, attribution that normalizes private, public, and academic filers to canonical entities, and continuous monitoring that keeps pace with a fast-funding field. Because fusion advances appear in scientific literature before they are patented, and because so much of the science is public while the engineering is proprietary, reading both patents and literature is essential to separate open physics from claimable engineering.

Where Cypris fits

Cypris runs patent landscape and white space analysis for engineering-intensive deep-tech fields such as commercial fusion energy across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by confinement approach, tokamak, stellarator, inertial, and others, and by enabling layer, magnets, heating and control, tritium breeding, materials, and targets, and normalizes private, public, and academic filers to canonical entities, so a team can resolve which approaches and layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying fusion-science research, which is where advances appear first and where public physics must be separated from proprietary engineering. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is the commercial fusion energy patent landscape? The commercial fusion energy patent landscape is the set of patents covering the technologies needed to build a fusion power plant. It spans confinement approaches, tokamaks, stellarators, inertial, and others, and enabling layers such as magnets, plasma heating and control, tritium breeding, first-wall materials, and inertial targets. Each is a distinct region of patenting.

Why are high-temperature superconducting magnets so important? High-temperature superconducting magnets are important because they reach much stronger magnetic fields than conventional superconductors, which allows far more compact and potentially cheaper fusion machines. They have become a central engineering and patenting focus across several confinement approaches, and the 2025 IAEA World Fusion Outlook gave them a special focus. Magnet design and superconducting-tape manufacturing are high-value layers.

Why is tritium breeding a key white space? Tritium breeding is a key white space because a deuterium-tritium plant must produce more tritium than it consumes to be self-sufficient, and this has not been demonstrated at commercial scale. The breeding blanket must also capture the fusion energy and survive neutron flux. That combination makes it a critical, comparatively open engineering layer.

What did the NIF ignition result actually show? The National Ignition Facility achieved fusion ignition in December 2022, producing about 3.15 megajoules of fusion energy from about 2.05 megajoules of laser energy delivered to the target. This is a scientific, target-level energy gain, not a net-grid gain, because the laser system draws far more energy from the grid than reaches the target. Later experiments repeated ignition.

How does public physics affect fusion IP? Public physics affects fusion IP because decades of open, publicly funded research placed much of the underlying plasma physics in the public domain, so the proprietary, patentable value concentrates in the specific engineering, magnets, blankets, materials, targets, and control systems, that turns physics into a working machine. Distinguishing public science from claimable engineering is central to fusion freedom-to-operate.

Where is the white space in fusion energy? The white space includes high-temperature superconducting magnets and their manufacturing, tritium breeding blankets, first-wall and divertor materials, plasma heating and control including machine-learning approaches, and inertial targets and drivers. The physics is largely public. The most open, high-value opportunities are in the engineering layers that remain unproven at commercial scale.

Why does fusion analysis need scientific literature? Fusion analysis needs scientific literature because so much of the field's knowledge is in public research, and new engineering advances appear in the literature before they are patented, so reading both is essential to separate open physics from claimable engineering. Analyzing patents alone gives a partial view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the fusion energy patent landscape? Software for the fusion landscape should cluster activity by confinement approach and enabling layer, resolve private, public, and academic filers to canonical owners, search patents and scientific literature semantically, and monitor a fast-funding field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Endnotes

1. Chapman, T. D., Ralph, J. E., Woodworth, B., et al. (2024). Present understanding of ignition and gain using indirect-drive inertial confinement fusion on the U.S. National Ignition Facility. Plasma Physics and Controlled Fusion, 67(1). https://doi.org/10.1088/1361-6587/ad994f
2. Creely, A. J., Rice, J. E., Sorbom, B. N., Hartwig, Z. S., et al. (2022). Overview of the SPARC physics basis toward burning-plasma regimes in high-field, compact tokamaks. Nuclear Fusion, 62(4). https://doi.org/10.1088/1741-4326/ac1654
3. Costley, A. E. (2016). On the fusion triple product and fusion power gain of tokamak pilot plants and reactors. Nuclear Fusion, 56(6). https://doi.org/10.1088/0029-5515/56/6/066003
4. Chen, W., & Zhong, W. (2025). Breakthrough in China's fusion energy: HL-3 tokamak achieves high ion temperature and fusion triple product. The Innovation, 6. https://doi.org/10.1016/j.xinn.2025.101167
5. Sakharov, N. V., et al. (2021). Tenfold increase in the fusion triple product in the spherical tokamak Globus-M2. Nuclear Fusion, 61(6). https://doi.org/10.1088/1741-4326/abe08c
6. Zhou, Y., Sadler, J. D., & Hurricane, O. A. (2024). Instabilities and mixing in inertial confinement fusion. Annual Review of Fluid Mechanics, 57. https://doi.org/10.1146/annurev-fluid-022824-110008
7. U.S. Department of Energy (2022, December 13). DOE National Laboratory makes history by achieving fusion ignition. https://www.energy.gov/articles/doe-national-laboratory-makes-history-achieving-fusion-ignition
8. ITER Organization (2024). New baseline to prioritize a robust start to exploitation. https://www.iter.org/node/20687/new-baseline-prioritize-robust-start-exploitation
9. International Atomic Energy Agency (2025). Fusion energy in 2025: six global trends to watch (World Fusion Outlook 2025). https://www.iaea.org/newscenter/news/fusion-energy-in-2025-six-global-trends-to-watch

‍

Silicon photonics has moved to the center of AI infrastructure, and its patent landscape is being staked out as data centers hit a wall that electrical interconnects cannot cross. As AI clusters scale to enormous numbers of accelerators, the energy and bandwidth cost of moving data over copper between chips, boards, and racks has become a dominant constraint, and peer-reviewed work frames high-bandwidth-density, energy-efficient optical interconnects as the leading answer.¹,² The technology arrives in several forms, each a distinct region of patenting: co-packaged optics, which place the optical engine in the same package as the switch or accelerator; optical input-output chiplets that bring light directly to the compute die; and silicon-photonic network switches. The intellectual property divides across the photonic devices themselves, such as modulators and detectors; the photonic-electronic integration and advanced packaging that combine light and electronics; the laser and light-source technologies that feed them; and the system-level architecture that ties them into an AI fabric. Because a working optical interconnect depends on several of these layers, freedom-to-operate and white space analysis must span them together.

The landscape is moving from roadmap to product very quickly, and it is quantitatively demanding. Peer-reviewed co-packaged transceivers now report energy efficiencies on the order of 3 picojoules per bit at hundreds of gigabits per second per channel, and advanced through-silicon and through-glass interposer packaging has demonstrated bandwidths beyond 67 and 110 gigahertz, illustrating both the device-level and packaging-level progress.³,⁶,⁷ Standardization is advancing alongside the hardware: the chiplet-interconnect standard released a new version in August 2025 adding higher data rates and extended reach, shaping how photonic engines connect to compute.⁸,⁹ Major networking and accelerator vendors have introduced co-packaged optical switches and optical I/O, but the competitive structure is layered rather than winner-take-all. Across the Cypris corpus of more than 500 million patents and scientific papers, the silicon-photonics, co-packaged-optics, and optical-interconnect space holds on the order of 102,700 de-duplicated families and has grown steadily and with acceleration, and the most active assignees are systems and networking vendors and foundries and research institutes, led by firms such as Intel, Huawei, IBM, NTT, TSMC, Cisco, and Marvell together with foundries and research organizations such as GlobalFoundries and imec, rather than pure-play startups, which do not appear in the top tier; the United States leads on geography, followed by China, Japan, and Taiwan. Because applications publish about eighteen months after filing, the most recent modulator, integration, and packaging filings are under-represented (2025 counts are partial), so the current frontier is more active than granted-patent counts suggest.

The strategic question is which layer to own, and the white space sits where physics and manufacturing are hardest. High-speed, low-power modulators are a foundational device layer where efficiency gains translate directly into system power savings, and microring-based modulator designs are a central approach.⁴,⁵ Photonic-electronic integration and packaging, bringing light reliably to the compute die at yield and scale, is the central manufacturing challenge and where much of the defensible, hard-to-design-around IP is concentrating.⁶,⁷ In the Cypris corpus, the modulator and light-source layers are the most heavily patented, followed by integration and packaging and then optical I/O, so laser and light-source integration is a distinct and contested layer, and system-level architecture, how optical links reshape the AI fabric, is where differentiation is won. Reading the landscape by layer and by owner, and tracking both the patents and the underlying photonics research, is what separates a crowded region from an open one.

Where the silicon photonics white space is

High-speed, low-power modulators. Modulators that raise data rates while cutting energy per bit are a foundational device layer where gains flow straight to system power.⁴,⁵

Photonic-electronic integration and packaging. Bringing light to the compute die at yield and scale is the central manufacturing challenge and where much hard-to-design-around IP concentrates.⁶,⁷

Laser and light-source integration. Efficient, reliable on- and off-package light sources are a distinct and contested layer, and among the most heavily patented in the corpus.

Optical I/O chiplets and interfaces. Chiplet-based optical I/O and the standardized interfaces that connect it to compute are an active, fast-moving layer.⁸,⁹

System-level optical architecture. Designs that reshape the AI fabric around optical links, including optical switching, are where system differentiation is won.

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans photonic devices, integration and packaging, light sources, and system architecture, in a field moving from roadmap to product month to month, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by layer across varied terminology, attribution that normalizes vendor, foundry, and startup filers to canonical entities, and continuous monitoring that keeps pace with a fast-moving field. Because silicon-photonics advances appear in scientific and conference literature before they are patented, reading both patents and literature gives the earliest signal of where the frontier and the white space are moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for fast-moving deep-tech fields such as silicon photonics for AI across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by layer, photonic device, integration and packaging, light source, optical I/O, and system architecture, and normalizes vendor, foundry, and startup filers to canonical entities, so a team can resolve which layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying photonics research, which is where silicon-photonics advances appear first, often well ahead of the patent record. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is silicon photonics central to AI infrastructure? Silicon photonics is central to AI infrastructure because AI clusters have grown so large that moving data over copper between chips, boards, and racks consumes too much power and limits bandwidth. Optical interconnects move data as light, cutting interconnect power and raising bandwidth. That is why co-packaged optics and optical I/O have moved from roadmap to product.

What layers does the silicon photonics landscape cover? The landscape covers photonic devices such as modulators and detectors, photonic-electronic integration and advanced packaging, laser and light-source technologies, optical I/O chiplets and interfaces, and system-level optical architecture. Each is a distinct region of patenting with different owners. Freedom-to-operate and white space analysis must span them together.

Who holds the IP in silicon photonics for AI? In the Cypris corpus, the most active assignees are systems and networking vendors, foundries, and research institutes, rather than pure-play startups, which do not appear in the top tier. Ownership is distributed across the stack, from modulators and integration to light sources and architecture. That layered structure makes landscape analysis valuable.

Where is the white space in silicon photonics? The white space includes high-speed, low-power modulators, photonic-electronic integration and packaging, laser and light-source integration, optical I/O chiplets and interfaces, and system-level optical architecture. Integration and packaging is the central manufacturing challenge and where much hard-to-design-around IP concentrates. The modulator and light-source layers are the most heavily patented in the corpus.

Why is integration and packaging so important? Integration and packaging is important because the hardest part of optical interconnects is bringing light reliably to the compute die at high yield and large scale. Solving this at manufacturable cost is what turns a device advantage into a system advantage. Much of the defensible, hard-to-design-around IP is concentrating there.

Why does silicon photonics analysis need scientific literature? Silicon photonics analysis needs scientific literature because device, integration, and light-source advances appear in research and conference proceedings before they are patented, so the literature gives the earliest signal in a fast-moving field. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the silicon photonics patent landscape? Software for the silicon photonics landscape should cluster activity by device, integration, light-source, and architecture layer, resolve vendor, foundry, and startup filers to canonical owners, search patents and scientific literature semantically, and monitor a fast-moving field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use silicon photonics patent landscape analysis? Silicon photonics patent landscape analysis is used by R&D, IP, and strategy teams at semiconductor, networking, photonics, and data-center companies, as well as investors assessing the sector. Because ownership is distributed across the stack and the field is moving fast, structured analysis is essential. Cypris serves hundreds of enterprise customers across research-intensive and regulated industries.

Endnotes

1. Novick, A., James, A., Wu, L. Y., Hattink, M., et al. (2023). High-bandwidth-density silicon photonic resonators for energy-efficient optical interconnects. Applied Physics Reviews, 10(3). https://doi.org/10.1063/5.0160441
2. Priyadarshi, S. (2025). Unlocking the potential of co-packaged optics in AI and HPC: opportunities and challenges. IEEE Communications Magazine. https://doi.org/10.1109/mcom.001.2500504
3. Li, X., Li, Y., Zhao, Y., Zhong, K., et al. (2025). Monolithically integrated 4×128 Gb/s, 3.07 pJ/bit silicon photonic transceiver for co-packaged optics. Optics Express, 33. https://doi.org/10.1364/oe.577010
4. Wu, Y., He, J., Cao, Y., & Liu, L. (2022). The high-efficiency co-design and measurement verification of high-bandwidth silicon photonic microring modulator. IET Optoelectronics, 16(6). https://doi.org/10.1049/ote2.12070
5. Titriku, A., Palermo, S., Chen, C.-H., Fiorentino, M., et al. (2015). Silicon photonic microring resonator-based transceivers for compact WDM optical interconnects. IEEE Compound Semiconductor Integrated Circuit Symposium (CSICS). https://doi.org/10.1109/csics.2015.7314523
6. Molnar, A., Ou, Y., Khilwani, D., et al. (2025). Scaling co-packaged optical interconnects using hybrid 2.5D/3D integration. IEEE International Symposium on Circuits and Systems (ISCAS). https://doi.org/10.1109/iscas56072.2025.11043946
7. Liu, S., Zhang, Y., Ge, C., Du, Y., et al. (2026). High-density co-packaged optics based on TSV and TGV interposers. Advanced Photonics Nexus, 5(3). https://doi.org/10.1117/1.apn.5.3.036019
8. UCIe Consortium. Universal Chiplet Interconnect Express (UCIe) specifications. https://www.uciexpress.org/specifications
9. Das Sharma, D., et al. (2024). High-performance, power-efficient three-dimensional system-in-package designs with universal chiplet interconnect express. Nature Electronics, 7. https://doi.org/10.1038/s41928-024-01126-y

‍

CAR-T cell therapy has one of the most academically rooted and legally tested patent landscapes in biotechnology. A chimeric antigen receptor T-cell is engineered by giving a patient's T-cells a synthetic receptor that directs them against a cancer target, and the intellectual property spans several distinct layers: the CAR construct itself, with its antigen-binding domain, hinge, transmembrane region, costimulatory domain, and signaling domain; the viral vectors used to introduce it; the manufacturing and cell-processing methods; and the methods of use for specific indications. Because these layers are patented separately and often by different owners, freedom-to-operate for a CAR-T product is a multi-layer, multi-owner analysis rather than a single clearance.

The foundational patents emerged from academic laboratories and were then in-licensed or acquired by commercial developers, which shaped the ownership structure. Peer-reviewed analyses of CAR-T patenting activity trace the field's key early filings to academic groups, with foundational work associated with Carl June at the University of Pennsylvania and Michel Sadelain at Memorial Sloan Kettering Cancer Center, before commercialization by large pharmaceutical companies.¹,² This academic origin is visible in the ownership record: across the Cypris corpus of more than 500 million patents and scientific papers, the most active assignees in the CAR-T set are led by the University of Pennsylvania, followed by the US Department of Health and Human Services and the National Institutes of Health, the University of California San Diego, the University of Texas System, and Memorial Sloan Kettering, interleaved with commercial developers such as Novartis, Juno Therapeutics, and Kite Pharma. Peer-reviewed patent-landscape analyses describe a field of fierce competition and intensive academic-industry collaboration,¹ with one review mapping more than 1,600 patent families across the field's technological routes,³ and product-patent-linkage studies have detailed how the portfolios behind approved CAR-T products are assembled from the construct, vector, manufacturing, and method-of-use layers.⁴ Analyses of academic CAR-T patenting also document the pitfalls that arise when university filings are drafted for disclosure rather than durable claim scope.⁵ A recurring finding is that many foundational filings date to the late 1990s and early 2000s, so their earliest members are now reaching the end of their patent terms, which shifts value toward improvement patents on next-generation constructs, allogeneic and off-the-shelf approaches, and manufacturing.¹,³ Across the Cypris corpus, CAR-T patent families grew from about 2,882 in 2018 to about 9,118 in 2024, with 2025 counts partial because of the roughly eighteen-month publication lag.

Litigation defined the landscape's risk profile. In the dispute between Juno Therapeutics, which exclusively licensed a foundational receptor patent from Memorial Sloan Kettering, and Kite Pharma over its approved therapy, a jury initially found for Juno, but on August 26, 2021 the US Court of Appeals for the Federal Circuit reversed and held the foundational patent's asserted claims invalid for lack of adequate written description, reasoning that disclosing a small number of specific binding domains did not show possession of the far broader claimed genus.⁶ A peer-reviewed analysis in Biotechnology Law Report situated the decision as a strike against broadly drafted, pioneering biotechnology claims.⁷ The decision reshaped the field, because it raised questions about the validity of broadly drafted foundational biotech patents generally, and it signaled that in cell therapy the durable value may lie in specific, well-supported improvement claims rather than pioneering-but-broad foundational ones. Because applications publish about eighteen months after filing, the most recent activity in next-generation and allogeneic approaches is under-represented, so the current frontier is more active than granted-patent counts suggest.

What creates FTO risk in CAR-T products

CAR construct claims. These cover the receptor's components, including antigen-binding domain, costimulatory domain, and signaling domain, the core of many disputes.

Viral vector claims. These cover the vectors used to introduce the receptor, a distinct and separately owned layer.

Manufacturing and cell-processing claims. These cover how the therapy is produced, which is increasingly where competitive differentiation and IP concentrate.

Method-of-use claims. These cover use for specific indications and patient populations, so a construct can be free for one use and blocked for another.

Next-generation and allogeneic claims. These cover off-the-shelf, gene-edited, and next-generation approaches, a fast-growing layer where new FTO risk and white space are emerging.

How AI-powered landscape and FTO analysis helps

A multi-layer, academically rooted, litigated landscape is beyond manual clearance. AI-powered analysis addresses this with semantic search that retrieves relevant construct, vector, manufacturing, and use claims regardless of terminology, attribution that resolves academic and commercial owners to canonical entities and captures the license and acquisition chains, and continuous monitoring that tracks next-generation filings and litigation developments. Because cell-therapy advances appear in scientific literature before they are patented, reading both patents and literature gives earlier warning.

Where Cypris fits

Cypris runs patent landscape and freedom-to-operate analysis for multi-layer, academically rooted fields such as CAR-T across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters the landscape by layer, construct, vector, manufacturing, and use, and normalizes academic and commercial owners to canonical entities, so a team can trace how rights and licenses are distributed rather than read a flat list. Semantic search across patents and scientific literature surfaces relevant claims regardless of terminology and connects filings to the underlying research, which is where next-generation and allogeneic approaches emerge first. Cypris Q, the platform's agentic layer, lets teams run landscape and FTO analysis conversationally and chain the attribution, clustering, and claim-level analysis, and Agentic Monitoring tracks the landscape over time and flags new filings and developments as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is the CAR-T patent landscape distinctive? The CAR-T patent landscape is distinctive because it is deeply rooted in academic research and has been heavily litigated. Foundational patents came from university labs and were licensed or acquired by commercial developers, and the IP spans the receptor construct, viral vectors, manufacturing, and methods of use. Freedom-to-operate is therefore a multi-layer, multi-owner analysis.

What claim types create FTO risk in CAR-T? Five claim types create FTO risk in CAR-T: CAR construct claims, viral vector claims, manufacturing and cell-processing claims, method-of-use claims, and next-generation or allogeneic claims. Each is independently patentable and can be held by a different owner. Construct and manufacturing layers are especially contested.

What was the Juno v. Kite decision? In Juno v. Kite, Juno Therapeutics asserted a foundational CAR receptor patent it had licensed from Memorial Sloan Kettering against Kite Pharma's approved therapy. A jury initially found for Juno, but the US Court of Appeals for the Federal Circuit in 2021 reversed and struck down the foundational patent for lack of adequate written description. The decision reshaped the field and raised questions about broadly drafted foundational biotech patents.

Why are CAR-T foundational patents reaching the end of their terms important? Many CAR-T foundational filings date to the late 1990s and early 2000s, so their earliest members are now reaching the end of their patent terms, which shifts value away from the original broad claims toward improvement patents. These cover next-generation constructs, allogeneic and off-the-shelf approaches, and manufacturing. FTO analysis must therefore focus increasingly on the improvement layer.

Where did CAR-T foundational patents come from? CAR-T foundational patents came largely from academic laboratories, with key work associated with Carl June at the University of Pennsylvania and Michel Sadelain at Memorial Sloan Kettering Cancer Center. These filings were in-licensed or acquired by commercial developers who brought products to market. This academic origin shaped the landscape's ownership and licensing structure, which is visible in the assignee record.

Why does CAR-T analysis need scientific literature? CAR-T analysis needs scientific literature because construct, manufacturing, and next-generation advances appear in research before they are patented, so the literature gives the earliest signal of where the field is heading. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

Which teams need CAR-T patent landscape and FTO analysis? CAR-T patent landscape and FTO analysis is needed by R&D, IP, and business-development teams at cell-therapy and pharmaceutical companies, academic technology-transfer offices, and investors assessing cell-therapy assets. The multi-layer, litigated landscape makes structured analysis essential. Cypris serves hundreds of enterprise customers across pharmaceuticals and other research-intensive industries.

How current does a CAR-T landscape need to be? A CAR-T landscape needs to be continuously current, because foundational patents are reaching the end of their terms, next-generation and allogeneic filings publish constantly, and publication lag hides the most recent activity. A one-time landscape ages quickly. Cypris uses Agentic Monitoring to track the landscape and flag new filings and developments as they publish.

‍
Endnotes

1. Lyu, L., Chen, X., Hu, Y., & Feng, Y. (2020). The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape. Nature Biotechnology, 38(12). https://doi.org/10.1038/s41587-020-00749-8
2. Clarke, N. S., & Jürgens, B. (2019). Evolution of CAR T-cell immunotherapy in terms of patenting activity. Nature Biotechnology, 37(4). https://doi.org/10.1038/s41587-019-0083-5
3. Malmegrim, K. C. R., Picanço-Castro, V., Pereira, C. G., Covas, D. T., Porto, G. S., & Swiech, K. (2019). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16(6). https://doi.org/10.1080/21645515.2019.1689744
4. Kano, S., & Kawai, Y. (2025). Expanding the concept of drug lifecycle management to chimeric antigen receptor T-cell products through product-patent linkage analysis. World Patent Information, 81. https://doi.org/10.1016/j.wpi.2025.102357
5. Constantinescu, C., Gulei, D., Bergþorsson, J. Þ., Coliţă, A., Tănase, A., Tomuleasa, C., Greiff, V., & Constantinescu, R. (2023). Pitfalls in patenting academic CAR-T cells therapy. Expert Opinion on Therapeutic Patents, 33(6). https://doi.org/10.1080/13543776.2023.2220883
6. U.S. Court of Appeals for the Federal Circuit (Aug. 26, 2021). Juno Therapeutics, Inc. v. Kite Pharma, Inc., 10 F.4th 1330. https://www.cafc.uscourts.gov/opinions-orders/20-1758.opinion.8-26-2021_1825257.pdf
7. Holman, C. M. (2021). In Juno v. Kite the Federal Circuit strikes down patent directed towards pioneering innovation in CAR T-cell therapy. Biotechnology Law Report, 40(6). https://doi.org/10.1089/blr.2021.29252.cmh

‍